EASY-Diabetes SIGNED

Project "EASY-Diabetes" data sheet

The following table provides information about the project.

 Partnership

Take a look of project's partnership.

Map

 Project objective

EASY – Diabetes is a digital health solution that helps patients with Type 2 diabetes and health care providers analyse data and make better decisions about therapies by accessing a carefully curated global database based on clinical data and medical evidence collected over the course of nine years and powered by machine learning algorithms and other forms of artificial intelligence. We offer EASY-Diabetes as a Software-as-a-Service to healthcare providers at a fee of €50 per patient per year. Diabetes is a prevalent and costly chronic disease, affecting 425 million people worldwide. Although 9.2% of the health care budget in Europe spent on diabetes, the results for patients remain inadequate even in the most advanced healthcare systems. Patients lack a patient-centred and personalised approach to disease management. 90% of patients with T2D are treated by GPs in primary care. Most clinics lack both the manpower and the expertise required to deal with the needs of patients for regular contact with health care providers and the complexity of diabetes treatment. Existing eHealth solutions show some crucial drawbacks, such as lack of clinical validation against the standard of care, no personalised medical treatment options, not being drug agnostic. Our team brings together demonstrated expertise in medicine, clinical trials, drug development, regulatory affairs, product development, programming, machine learning, business development. The SME Phase 1 Feasibility study will aim to complete the validation of the commercial feasibility of Easy – Diabetes with target market segments and key stakeholders. We will strengthen our financial planning and IP protection strategy necessary to improve our service and refine our go-to-market strategy.